These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
246 related articles for article (PubMed ID: 34329659)
1. Cytokine Stimulation by MRGPRX2 Occurs with Lower Potency than by FcεRI Aggregation but with Similar Dependence on the Extracellular Signal-Regulated Kinase 1/2 Module in Human Skin Mast Cells. Wang Z; Franke K; Zuberbier T; Babina M J Invest Dermatol; 2022 Feb; 142(2):414-424.e8. PubMed ID: 34329659 [TBL] [Abstract][Full Text] [Related]
2. Cytokines Stimulated by IL-33 in Human Skin Mast Cells: Involvement of NF-κB and p38 at Distinct Levels and Potent Co-Operation with FcεRI and MRGPRX2. Franke K; Wang Z; Zuberbier T; Babina M Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33808264 [TBL] [Abstract][Full Text] [Related]
3. IL-33 and MRGPRX2-Triggered Activation of Human Skin Mast Cells-Elimination of Receptor Expression on Chronic Exposure, but Reinforced Degranulation on Acute Priming. Wang Z; Guhl S; Franke K; Artuc M; Zuberbier T; Babina M Cells; 2019 Apr; 8(4):. PubMed ID: 30979016 [TBL] [Abstract][Full Text] [Related]
4. MRGPRX2-Mediated Degranulation of Human Skin Mast Cells Requires the Operation of G Wang Z; Franke K; Bal G; Li Z; Zuberbier T; Babina M Cells; 2022 Mar; 11(6):. PubMed ID: 35326404 [TBL] [Abstract][Full Text] [Related]
5. MRGPRX2 is negatively targeted by SCF and IL-4 to diminish pseudo-allergic stimulation of skin mast cells in culture. Babina M; Wang Z; Artuc M; Guhl S; Zuberbier T Exp Dermatol; 2018 Nov; 27(11):1298-1303. PubMed ID: 30091263 [TBL] [Abstract][Full Text] [Related]
6. Thymic Stromal Lymphopoietin Promotes MRGPRX2-Triggered Degranulation of Skin Mast Cells in a STAT5-Dependent Manner with Further Support from JNK. Babina M; Wang Z; Franke K; Zuberbier T Cells; 2021 Jan; 10(1):. PubMed ID: 33429916 [TBL] [Abstract][Full Text] [Related]
7. Synergism between IL-33 and MRGPRX2/FcεRI Is Primarily Due to the Complementation of Signaling Modules, and Only Modestly Supplemented by Prolonged Activation of Selected Kinases. Franke K; Li Z; Bal G; Zuberbier T; Babina M Cells; 2023 Nov; 12(23):. PubMed ID: 38067128 [TBL] [Abstract][Full Text] [Related]
8. Peripheral blood cultured mast cells: Phenotypic and functional outcomes of different culture protocols. Elst J; Sabato V; van der Poorten MM; Faber M; Van Gasse AL; De Puysseleyr LP; Bridts CH; Mertens C; Van Houdt M; Maurer M; Hagendorens MM; Ebo DG J Immunol Methods; 2021 May; 492():113003. PubMed ID: 33647250 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of MRGPRX2 but not FcεRI or MrgprB2-mediated mast cell degranulation by a small molecule inverse receptor agonist. Bawazir M; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H Front Immunol; 2022; 13():1033794. PubMed ID: 36275683 [TBL] [Abstract][Full Text] [Related]
10. MRGPRX2 Is the Codeine Receptor of Human Skin Mast Cells: Desensitization through β-Arrestin and Lack of Correlation with the FcεRI Pathway. Babina M; Wang Z; Roy S; Guhl S; Franke K; Artuc M; Ali H; Zuberbier T J Invest Dermatol; 2021 May; 141(5):1286-1296.e4. PubMed ID: 33058860 [TBL] [Abstract][Full Text] [Related]
11. Angiogenic Host Defense Peptide AG-30/5C and Bradykinin B Roy S; Ganguly A; Haque M; Ali H J Immunol; 2019 Feb; 202(4):1229-1238. PubMed ID: 30651343 [TBL] [Abstract][Full Text] [Related]
12. Human Mast Cell Line HMC1 Expresses Functional Mas-Related G-Protein Coupled Receptor 2. Hermans MAW; van Stigt AC; van de Meerendonk S; Schrijver B; van Daele PLA; van Hagen PM; van Splunter M; Dik WA Front Immunol; 2021; 12():625284. PubMed ID: 33790895 [TBL] [Abstract][Full Text] [Related]
13. Inflamed Ulcerative Colitis Regions Associated With MRGPRX2-Mediated Mast Cell Degranulation and Cell Activation Modules, Defining a New Therapeutic Target. Chen E; Chuang LS; Giri M; Villaverde N; Hsu NY; Sabic K; Joshowitz S; Gettler K; Nayar S; Chai Z; Alter IL; Chasteau CC; Korie UM; Dzedzik S; Thin TH; Jain A; Moscati A; Bongers G; Duerr RH; Silverberg MS; Brant SR; Rioux JD; Peter I; Schumm LP; Haritunians T; McGovern DP; Itan Y; Cho JH Gastroenterology; 2021 Apr; 160(5):1709-1724. PubMed ID: 33421512 [TBL] [Abstract][Full Text] [Related]
14. Allergic FcεRI- and pseudo-allergic MRGPRX2-triggered mast cell activation routes are independent and inversely regulated by SCF. Babina M; Guhl S; Artuc M; Zuberbier T Allergy; 2018 Jan; 73(1):256-260. PubMed ID: 28859248 [TBL] [Abstract][Full Text] [Related]
15. GRK2 differentially regulates FcεRI and MRGPRB2-mediated responses in mast cells. Thapaliya M; Ali H Front Immunol; 2023; 14():1155777. PubMed ID: 37063868 [TBL] [Abstract][Full Text] [Related]
16. MRGPRX2, drug pseudoallergies, inflammatory diseases, mechanisms and distinguishing MRGPRX2- and IgE/FcεRI-mediated events. Baldo BA Br J Clin Pharmacol; 2023 Nov; 89(11):3232-3246. PubMed ID: 37430437 [TBL] [Abstract][Full Text] [Related]
17. GRK2 inhibitors, paroxetine and CCG258747, attenuate IgE-mediated anaphylaxis but activate mast cells Thapaliya M; Amponnawarat A; Tesmer JJG; Ali H Front Immunol; 2022; 13():1032497. PubMed ID: 36275707 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of Orai Channel Function Regulates Mas-Related G Protein-Coupled Receptor-Mediated Responses in Mast Cells. Chaki S; Alkanfari I; Roy S; Amponnawarat A; Hui Y; Oskeritzian CA; Ali H Front Immunol; 2021; 12():803335. PubMed ID: 35126366 [TBL] [Abstract][Full Text] [Related]
19. MRGPRX2 signals its importance in cutaneous mast cell biology: Does MRGPRX2 connect mast cells and atopic dermatitis? Wang Z; Babina M Exp Dermatol; 2020 Nov; 29(11):1104-1111. PubMed ID: 32866307 [TBL] [Abstract][Full Text] [Related]
20. MRGPRX2 activation as a rapid, high-throughput mechanistic-based approach for detecting peptide-mediated human mast cell degranulation liabilities. Lafleur MA; Werner J; Fort M; Lobenhofer EK; Balazs M; Goyos A J Immunotoxicol; 2020 Dec; 17(1):110-121. PubMed ID: 32525431 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]